Office of the Press Secretary
For Immediate Release
April 4, 2003
By the authority vested in me as President by the Constitution and the laws of the United States of America, including section 361(b) of the Public Health Service Act (42 U.S.C. 264(b)), it is hereby ordered as follows:
Section 1. Based upon the recommendation of the Secretary of Health and Human Services (the “Secretary”), in consultation with the Surgeon General, and for the purpose of specifying certain communicable diseases for regulations providing for the apprehension, detention, or conditional release of individuals to prevent the introduction, transmission, or spread of suspected communicable diseases, the following communicable diseases are hereby specified pursuant to section 361(b) of the Public Health Service Act:
(a) Cholera; Diphtheria; infectious Tuberculosis; Plague; Smallpox; Yellow Fever; and Viral Hemorrhagic Fevers (Lassa, Marburg, Ebola, Crimean-Congo, South American, and others not yet isolated or named).
(b) Severe Acute Respiratory Syndrome (SARS), which is a disease associated with fever and signs and symptoms of pneumonia or other respiratory illness, is transmitted from person to person predominantly by the aerosolized or droplet route, and, if spread in the population, would have severe public health consequences.
Sec. 2. The Secretary, in the Secretary’s discretion, shall determine whether a particular condition constitutes a communicable disease of the type specified in section 1 of this order.
Sec. 3. The functions of the President under sections 362 and 364(a) of the Public Health Service Act (42 U.S.C. 265 and 267(a)) are assigned to the Secretary.
Sec. 4. This order is not intended to, and does not, create any right or benefit enforceable at law or equity by any party against the United States, its departments, agencies, entities, officers, employees or agents, or any other person.
Sec. 5. Executive Order 12452 of December 22, 1983, is hereby revoked.
George W. Bush
The White House,
April 4, 2003.
CLICK ON PHOTO:
CLICK ON THE PHOTO TO READ MORE ON IT :
As the Ebola outbreak continues to cause concern, President Barack Obama has signed an amendment to an executive order that would allow him to mandate the apprehension and detention of Americans who merely show signs of “respiratory illness.”
The executive order, titled Revised List of Quarantinable Communicable Diseases, amends executive order 13295, passed by George W. Bush in April 2003, which allows for the, “apprehension, detention, or conditional release of individuals to prevent the introduction, transmission, or spread of suspected communicable diseases.”
The amendment signed by Obama replaces subsection (b) of the original Bush executive order which referred only to SARS. Obama’s amendment allows for the detention of Americans who display, “Severe acute respiratory syndromes, which are diseases that are associated with fever and signs and symptoms of pneumonia or other respiratory illness, are capable of being transmitted from person to person, and that either are causing, or have the potential to cause, a pandemic, or, upon infection, are highly likely to cause mortality or serious morbidity if not properly controlled.”
Although Ebola was listed on the original executive order signed by Bush, Obama’s amendment ensures that Americans who merely show signs of respiratory illness, with the exception of influenza, can be forcibly detained by medical authorities.
Although the quarantining of people suspected of being infected with the Ebola virus seems like a perfectly logical move, the actual preconditions for this to happen aren’t restricted to just those suffering from the disease.
As we highlighted earlier this week, the Centers for Disease Control and Prevention (CDC) has measures in place for dealing with an outbreak of a communicable disease which allow for the quarantine of “well persons” who “do not show symptoms” of the disease.
In addition, under the Model State Emergency Health Powers Act, public health authorities and governors would be given expanded police powers to seize control of communications devices, public and private property, as well as a host of other draconian measures in the event of a public health emergency.
When the legislation was introduced, the Association of American Physicians and Surgeons warned that it “could turn governors into dictators.”
Yesterday it was reported that Emory University Hospital in Atlanta was set to receive a patient infected with Ebola. A hospital in Germany also accepted an infected patient earlier this week. Some critics have raised concerns about the risk of deliberately importing infected individuals into the west.
Tekmira Pharmaceuticals Corporation has dosed the first subject in a Phase 1 human clinical trial of TKM-Ebola, an anti-Ebola viral therapeutic that is being developed under a US$140 million contract with the U.S. Department of Defense.
Study to assess safety tolerability and pharmacokinetics of TKM-Ebola
Here is the link that proves the human testing was done Prior to the first case to show up in February. http://biotechnologyfocus.ca/tekmira-…
For those of you who thinks a cashless society is impossible, look ahead. It makes one think of Imposed RFID
The TKM-Ebola Phase 1 clinical trial is a randomized, single-blind, placebo-controlled study involving single ascending doses and multiple ascending doses of TKM-Ebola. The study will assess the safety, tolerability and pharmacokinetics of administering TKM-Ebola to healthy adult subjects. Four subjects will be enrolled per cohort. There are four planned cohorts for a total of 16 subjects in the single dose arm, and three planned cohorts for a total of 12 subjects in the multiple dose arm of the trial. Each cohort will enroll three subjects who receive TKM-Ebola, and one who will receive placebo.
Promising results in non-human primates
Earlier preclinical studies were published in the medical journal The Lancet and demonstrated that when siRNA targeting the Ebola virus and delivered by Tekmira’s LNP technology were used to treat previously infected non-human primates, the result was 100 per cent protection from an otherwise lethal dose of Zaire Ebola virus (Geisbert et al., The Lancet, Vol 375, May 29, 2010).
This work is being conducted under contract with the US Department of Defense’s (DoD) BioDefense Therapeutics (BD Tx), a Joint Product Manager within the Medical Countermeasure Systems (JPM-MCS) Joint Project Management Office. Tekmira’s collaboration with the JPM-MCS was modified and expanded in 2013 to include significant advances in LNP formulation technology since the initiation of the program in 2010.
How to make COLLOIDAL SILVER :
Items you need:
2 ft. common electric wire (any laying around in the house)
4 small alligator clamps ( $6 for 4 at the hardware store)
A bit of electric tape.
3 9V batteries ( about $ 10)
Distilled water $0.99
Saline (eyewash drops) $2-3.00
1 ft silver wire, 999.99 pure . $10-25.00, depending on gauge, a thin one will do fine.
A glass (for the electrolysis) no plastic or metal containersInstructions in the video.
You don’t need a box for the apparatus or soldering anything. twist the wires and cover with electric tape. Just connect your batteries in series to get 27 Volt.
When you are done, clean the oxidized wire with a rough cloth or soda, and store all the pieces in a zip-lock bag until next time.
Store colloidal silver in glass, away from light.============================
READ MORE ON GARLIC CLICK ON PHOTO :
Garlic for food and medicine – a brief history
Garlic has been used all over the world for thousands of years. Records indicate that garlic was in use when the Giza pyramids were built, about five thousand years ago.
Richard S. Rivlin wrote in the Journal of Nutrition1 that the ancient Greek physician Hippocrates (circa. 460-370 BC), known today as “the father of Western medicine”, prescribed garlic for a wide range of conditions and illnesses. Hippocrates promoted the use of garlic for treating respiratory problems, parasites, poor digestion and fatigue. The original Olympic athletes in Ancient Greece were given garlic – possibly the earliest example of “performance enhancing” agents used in sports.
From Ancient Egypt garlic spread to the advanced ancient civilizations of the Indus Valley (Pakistan and western India today). From there it made its way to China.
According to experts at Kew Gardens2, England’s royal botanical center of excellence, the people of ancient India valued the therapeutic properties of garlic and also thought it to be an aphrodisiac. The upper classes avoided garlic because they despised its strong odor, while monks, “…widows, adolescents and those who had taken up a vow or were fasting could not eat garlic because of its stimulant quality”.